Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Customized asthma treatment introduced in the U.S.

Sep. 20, 1996

LTD4 antagonist selected for further evaluation by Menarini

Sep. 20, 1996

Schering AG investigates LTB4 inhibitors

Sep. 20, 1996

5-LO inhibitor from Bristol-Myers Squibb

Sep. 20, 1996

Anti-IL-8 antibodies claimed by Genentech

Sep. 20, 1996

C5a receptor required for host defense in the lung

Sep. 13, 1996

Potential antiasthmatic agent from Lipha

Sep. 13, 1996

Novel PAF and 5-LO inhibitors reported by Sunkyong

Sep. 13, 1996

Improved agents for asthma

Sep. 13, 1996

Orally active dual NK1/NK2 antagonist from Merck & Co.

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026